1. Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function
- Author
-
Xiujuan Qu, Kiyonao Sada, Tomoko Hatani, S. M. Shahjahan Miah, and Hirohei Yamamura
- Subjects
MAPK/ERK pathway ,rac1 GTP-Binding Protein ,Blotting, Western ,RAC1 ,Cell Cycle Proteins ,IκB kinase ,Immunoglobulin E ,SH3BP2 ,Cell Line, Tumor ,Proto-Oncogene Proteins ,Genetics ,Animals ,Humans ,Immunoprecipitation ,Point Mutation ,Mast Cells ,Phosphorylation ,Proto-Oncogene Proteins c-vav ,Adaptor Proteins, Signal Transducing ,biology ,Kinase ,Degranulation ,Cherubism ,NFAT ,Cell Biology ,Cell biology ,Rats ,COS Cells ,Cancer research ,biology.protein ,Mitogen-Activated Protein Kinases - Abstract
Adaptor protein 3BP2 positively regulates the high affinity IgE receptor (FcepsilonRI)-mediated activation of degranulation in mast cells. Genetic study identified the point mutations of 3BP2 gene in human-inherited disease cherubism. The multiple cysts in cherubism lesion of jaw bones are filled with the activated osteoclasts and stromal cells, including mast cells. By over-expression study using rat basophilic leukaemia RBL-2H3 mast cells, we have analysed the effect of the point mutations on the function of 3BP2 protein, which plays a positive regulatory role on FcepsilonRI-mediated mast cell activation. Over-expression of 3BP2 mutants suppressed the antigen-induced degranulation and cytokine gene transcription. Antigen-induced phosphorylation of Vav1, activation of Rac1, extracellular signal regulated kinase (ERK), c-Jun N-terminal kinase (JNK), p38 mitogen activated protein kinase (MAPK), inhibitor of nuclear factor kappaB kinase (IKK) and nuclear factor of activated T cells (NFAT) were all impaired in the cells over-expressing the cherubism mutants of 3BP2. Furthermore, cherubism mutations of 3BP2 may abrogate the binding ability to interact with chaperone protein 14-3-3. These results demonstrate that over-expression of the mutant form of 3BP2 inhibits the antigen-induced mast cell activation. It suggests that point mutations of 3BP2 gene cause the dysfunction of 3BP2 in vivo.
- Published
- 2004